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Department of Population Health, University of Oxford, Oxford, UKA B S T R A C TBackground: Resource use measurement by patient recall is charac-
terized by inconsistent methods and a lack of validation. A validated
standardized resource use measure could increase data quality,
improve comparability between studies, and reduce research burden.
Objectives: To identify a minimum set of core resource use items that
should be included in a standardized adult instrument for UK health
economic evaluation from a provider perspective. Methods: Health
economists with experience of UK-based economic evaluations were
recruited to participate in an electronic Delphi survey. Respondents
were asked to rate 60 resource use items (e.g., medication names) on a
scale of 1 to 9 according to the importance of the item in a generic
context. Items considered less important according to predeﬁned
consensus criteria were dropped and a second survey was developed.
In the second round, respondents received the median score and
their own score from round 1 for each item alongside summarized
comments and were asked to rerate items. A ﬁnal project teammeetingee front matter & 2018 Published by Elsevier Inc.
(ISPOR). This is an open access article under the
1016/j.jval.2017.06.011
Patient and Public Involvement Representative.
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ondence to: Joanna C. Thorn, School of Social an
ol BS8 2PS, UK.was held to determine the recommended core set. Results: Forty-ﬁve
participants completed round 1. Twenty-six items were considered less
important and were dropped, 34 items were retained for the second
round, and no new items were added. Forty-two respondents (93.3%)
completed round 2, and greater consensus was observed. After the ﬁnal
meeting, 10 core items were selected, with further items identiﬁed as
suitable for “bolt-on” questionnaire modules. Conclusions: The con-
sensus on 10 items considered important in a generic context suggests
that a standardized instrument for core resource use items is feasible.
Keywords: cost measurement, patient-reported, randomized clinical
trial, resource use.
& 2018 Published by Elsevier Inc. on behalf of International Society for
Pharmacoeconomics and Outcomes Research (ISPOR). This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
For cost-effectiveness analyses to be optimal, resource use
measurement in randomized controlled trials (RCTs) must be
accurate. Nevertheless, to date, considerably more research has
been directed at improving outcome measurement methodolo-
gies (e.g., utilities) [1]. The methods used to measure costs are
poorly reported [2], and instruments to collect data directly from
patients are commonly not validated [3] (although there are
studies in which the reliability/validity of self-report is consid-
ered [4]). When available, routine data sources (e.g., electronic
hospital records) might reduce attrition bias, be more accurate,
and minimize the burden on trial participants. Routine data may,
however, not be readily available, consistent, or suitable for
costing purposes [5]. Electronic systems may also be costly to
access and may lack information on personal costs incurred by
patients. It is therefore likely that researchers will continue to bereliant on instruments based on patient recall (e.g., diaries, logs,
and questionnaires [6]) for some time, despite the fact that self-
reported data on health care use are of variable accuracy [7].
A signiﬁcant amount of work in recent years has focused on
developing core outcome sets (COSs), which are agreed minimum
sets of outcomes (often health-related) to be measured and
reported in all trials for a speciﬁc condition/treatment [8]. Stand-
ardization counteracts problems with researchers selecting out-
comes on the basis of their own expertise or the statistical
signiﬁcance of results. A standard set of outcomes also reduces
heterogeneity and improves comparability across trials [9].
Although developing a core set of resource use items has much
in common with COS development, there are also some impor-
tant differences. A fundamental consideration of an economic
analysis is the perspective, which leads to the inclusion of
different types of resource use. Although COSs are speciﬁc to
clinical conditions or treatments and are therefore differenton behalf of International Society for Pharmacoeconomics and
CC BY license (http://creativecommons.org/licenses/by/4.0/).
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perspective, but could potentially be generalizable across trials.
Separate measurement instruments may be required for out-
comes identiﬁed in COSs (e.g., the EuroQol ﬁve-dimensional
questionnaire for quality of life or the modiﬁed Health Assess-
ment Questionnaire for patient satisfaction with activities of
daily living [10]); in contrast, a core set of resource use items
would generally form a single instrument.
Standardization of resource use measurement is potentially
controversial among health economists. Legitimate concerns
about the study perspective, nature of the intervention, and type
of analysis planned may suggest that standardization is too
limiting. There is a trade-off between gathering as much infor-
mation as possible (with increased patient burden and possible
poor response rates) and gathering less information (which may
not allow an accurate analysis to be conducted). As Drummond
et al. [11p253] point out, “The skill in costing is to match the level
of precision (and effort) to the importance (in quantitative terms)
of the cost item.” Nevertheless, standardizing outcomes using the
EuroQol ﬁve-dimensional questionnaire is accepted in the United
Kingdom (and indeed required by the National Institute for
Health and Care Excellence [12]), despite the inevitable limitation
on the ﬂexibility of the instrument. In contrast, health econo-
mists typically generate new, or revise existing, resource use
instruments for RCTs on a case-by-case basis; some standardiza-
tion of cost measurement (albeit with “bolt-ons” to ensure more
complete coverage of resources) would allow greater compara-
bility between trials and would reduce the research effort
required. The signiﬁcant overlap between questions in instru-
ments held in the Database of Instruments for Resource Use
Measurement (www.dirum.org) [13] suggests that deﬁning a core
set may be feasible [14].
In our study (Items for a Standardised Resource-Use Measure,
ISRUM), we aim to identify core items of resource use that should
be included in any economic evaluation of a health care inter-
vention conducted in the United Kingdom. We aim to identify a
minimum set of items that should be measured, and not a
complete set; we anticipate that health economists may measure
additional items according to the particular nature of the RCT
and the perspective of the analysis. We use a Delphi survey to
seek consensus expert opinion.Methods
Approval for the study was granted by the Faculty of Health
Sciences Research Ethics Committee of the University of Bristol.
A patient and public involvement (PPI) representative was
recruited to the study team via the People in Health West of
England (http://www.phwe.org.uk/) mailing list.
Phase 1: Identiﬁcation of “Long List” and Development of
Survey
The identiﬁcation of a long list of resource use items is described
in detail elsewhere [14]. In brief, a review of measurement
instruments currently used in RCTs of health interventions was
undertaken; individual items were extracted by two researchers
and disagreements were resolved by discussion. Items were
scrutinized by a single researcher and overlapping items merged.
Similar types of items were combined; for example, doctor, nurse,
and allied health professional were collapsed into “professional
seen.” Items not relevant to a National Health Service (NHS) and
personal social services (PSS) perspective (commonly taken in UK
studies) were dropped. Remaining items were formulated as
individual questions for a Delphi survey. The Delphi method is
used increasingly for consensus in COSs [15]. It requires expertparticipants to provide their opinions in sequential question-
naires (rounds), with each round presenting group feedback from
the previous round. Anonymity of the responses is maintained to
ensure that no individual dominates the process [16]. A Web-
administered “eDelphi” survey was developed using REDCap
electronic data capture tools hosted at the University of Bristol
[17]; items were grouped according to the location in which the
care took place (e.g., hospital). The survey was piloted in the
study team, and a think-aloud Web usability study (in which
participants were asked to talk through their responses) was
conducted with a convenience sample to ensure it was compre-
hensible and manageable [18].
Phase 2: Prioritization of Resource Use Items
Stakeholders
Practicing health economists with experience of RCTs in the
United Kingdom were recruited to the Delphi panel. A generic
email was sent to the Health Economists’ Study Group mailing
list describing the preparatory work and purpose of the study and
inviting participation by following a Web link. Health economists
who had recently contributed to National Institute for Health
Research Health Technology Assessment reports (http://www.
journalslibrary.nihr.ac.uk/hta) or attended relevant workshops
were approached directly. One reminder email was sent. Com-
pletion of the ﬁrst questionnaire was deemed to represent
informed consent to participate. Demographic details were
requested in the survey including subgroups describing experi-
ence with different types of patient care (physical, mental, and
public health; older adults; primary and secondary care), length
of experience, and professional background.
Survey round 1
In round 1 of the survey, participants were asked to rate the
importance of retaining each item in the core standardized
resource use set on a scale of 1 (not important) to 9 (very
important). Participants were asked to think in terms of resource
use relevant to an NHS and PSS perspective for adult patients of
any age, living with wide-ranging physical and/or mental health
conditions of variable severity (see Appendix 1 in Supplemental
Materials found at http://dx.doi.org/10.1016/j.jval.2017.06.011).
They were asked to assume that there may be differences
between trial arms in any item and that they have no access to
any other source of resource use data (such as medical records).
Participants were encouraged to comment on their ratings and
suggest additional items. After completion of the questionnaire,
items for which the participant had scored 7 to 9 were presented
back to them, with a request to select their “top 10” items for the
core set. Round 1 item scores were summarized across partic-
ipants, and items to retain for round 2 were identiﬁed using
prespeciﬁed criteria; items suggested by participants were added
if they met prespeciﬁed criteria (see Analysis section).
Survey round 2
All participants who had completed round 1 of the survey were
emailed a Web link to the round 2 questionnaire. Feedback from
round 1 was presented for each round 2 item in the form of the
median score along with a reminder of the individual’s own
score. Comments in round 1 that were relevant to selection
choice were also summarized and presented, and changes were
made to the wording for a small number of items on the basis of
some of the comments. Participants were asked to rerate each
item (see Appendix 1 in Supplemental Materials) and were given
further opportunity to comment on their choices. A reminder
invitation was sent after 2 weeks, and a further reminder specify-
ing a closing date was issued 1 week later. Shortly after the
Fig. 1 – Flowchart of Delphi study participants through the study. HESG, Health Economists’ Study Group.
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request reasons for noncompletion.
Analyses
Statistical analyses were carried out in Stata 14 (StataCorp LP,
College Station, TX) [19] and were conducted according to a
prespeciﬁed analysis plan.
Criteria for retaining items
At the end of round 1, the percentage of participants scoring 7 to
9 (high priority) and 1 to 3 (low priority) was calculated for each
item, both for participants overall and for each of the “type of
experience” subgroups separately. Items were retained if scored 7
to 9 by more than 50% and 1 to 3 by less than 15% by participants
overall or within two or more subgroups of participants; these
prespeciﬁed criteria were deliberately inclusive. Items were also
retained if 15% or more of the participants prioritized the item in
their top 10 list. Items not meeting any of these criteria were
closely examined for overlap with retained items; if there was no
overlap, the item was further considered for retention. New itemswere added to round 2 if suggested by more than 10% of
participants.
After round 2, items were retained if scored 7 to 9 by more
than 70% and 1 to 3 by less than 15% of all participants. Because
further Delphi rounds were beyond the scope of this study, more
stringent criteria were also set (470% scoring an item 8 or 9 and
o15% scoring 1–3) to aid discussions in a ﬁnal item selection
meeting so that a pragmatic core set could be identiﬁed.Attrition
Nonresponders to round 2 were examined in terms of years of
experience; mean scores were compared with those from round 2
responders.Assessment of consensus
It is not a requirement of the Delphi process to achieve consensus
for all items (e.g., when all participants agreed on the high/low
priority grouping); it is, however, essential that participants agree
on a reduced number of items to be most important. It is
Table 1 – Characteristics of 45 Delphi participants
from round 1.
Characteristic n (%)
Length of experience
o5 y 11 (24.4)
5–10 y 12 (26.7)
10–20 y 11 (24.4)
420 y 11 (24.4)
Trial experience
Adults 44 (97.8)
Children 21 (46.7)
Older adults 26 (57.8)
Physical health conditions 38 (84.4)
Mental health conditions 28 (62.2)
Public health interventions 20 (44.4)
Primary care 33 (73.3)
Secondary care 39 (86.7)
Background
Academia 42 (93.3)
Other 3 (6.7)
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participants in both rounds and the degree of stability in scores.
For each round, the percentage of participants scoring 7 to 9
and 1 to 3 was examined for evidence of bimodality (deﬁned as
440% rating an item 7–9 and 440% rating it 1–3) for each item,
because this could indicate an irreconcilable difference of opin-
ion. The intraclass correlation coefﬁcient (two-way random
effects model) was calculated for both rounds, to give an indica-
tion of agreement within the survey [20].
For each item, the mean absolute change in score between
rounds was also calculated; a large change (deﬁned as ≥3 points)
could indicate instability. The percentage of people changing
their score by a small amount (1 or 2 points) and a large amount
(≥3 points) was calculated for each item to give an indication of
the stability of the results. Variation in changes to scores with
length of experience (categorized as o5 years, 5–10 years, 10–20
years, and 420 years) was explored through linear regression.
Finally, the SD of scores was calculated for each item (separately
for each round) as a measure of the spread in responses across
participants (and degree of agreement) and was used to calculate
the change in each item’s variability between rounds [21].Analysis of comments
Content analysis (a systematic approach to studying text that
aims to categorize and quantify content) was conducted for
comments by using nVivo software (QSR International Ltd.
London) [22,23]. Suggestions in round 1 for new items were
extracted, and broad themes were identiﬁed for both rounds.
Phase 3: Final Item Selection Meeting
The project team met to determine the ﬁnal core items to include
in a standardized “short form” resource use measure. Partici-
pants who had commented extensively during the Delphi process
or were associated with the Medical Research Council (MRC)
Network of Hubs for Trials Methodology Research were invited
to attend the meeting. Each item included in round 2 was
discussed in detail. The two prespeciﬁed criteria were applied
to the round 2 data to identify the items considered most crucial
(more stringent criteria) and very important (less stringent
criteria) for inclusion in the ﬁnal core set. Items reaching the
more stringent criteria were included in the ﬁnal set if consideredrelevant, by the team, to all trials and patient populations. If
relevant only to speciﬁc settings, items were included in sug-
gested bolt-on modules. Items reaching the less stringent criteria
were then discussed and merged with those already in the ﬁnal
set when appropriate or were considered as separate items for
the core set or as items in bolt-on modules. Remaining items
were examined to ensure that nothing vital was overlooked.Results
Phase 1
Items were extracted from 59 resource use instruments. After the
deduplication and merging processes, the long list contained 60
items, categorized as hospital care (n ¼ 15), emergency care (n ¼ 5),
care at a general practitioner (GP) surgery or health clinic (n ¼ 7),
care at home (n ¼ 7), remote access care (n ¼ 4), other community
care (n ¼ 6), residential care (n ¼ 10), and medication (n ¼ 6).
Usability studies with both a native and a non-native English
speaker indicated that the Delphi survey was comprehensible, and
completion was manageable.Phase 2
Forty-ﬁve participants provided usable responses to round 1; 41
completed the whole survey, whereas 4 supplied ratings for all
items, but did not select their top 10 (Fig. 1). Participants with a
range of experience were represented (Table 1), although almost
all (42 of 45) were working in academia. Application of the
predeﬁned consensus criteria identiﬁed 27 items to be retained
for round 2, considered to be of high priority by participants
overall. Four additional items were considered important by two
or more subgroups: minor surgery (important to participants with
experience of primary care, physical health, public health, or
older adults), living in either a residential home or a supported
accommodation (rated highly by participants with experience of
primary care, mental health, or older adults), and the period over
which medication is taken (important to respondents with
experience in primary care and public health). Type of ward
and scans were added because more than 15% of respondents
cited them in their top 10. Finally, equipment was identiﬁed as a
suitable addition because it came close to meeting several of the
aforementioned criteria and no other similar items were
included. No new items met the inclusion criteria. Thirty-four
items were therefore included for round 2 (Table 2) and 26 items
were dropped (Table 3). Engagement with the project in round 1
was good, with broadly positive comments indicating that
achieving consensus was feasible.
Out of 45 participants, 42 (93.3%) responded to round 2 (Fig. 1).
The three nonresponders each came from a different level of
experience. Nonresponders had a mean score of 8.53 ± 0.33 in
round 1 compared with 7.13 ± 1.09 for responders (P ¼ 0.03).
There was no evidence of bimodality for any item in either round.
All responding participants changed at least one rating between
rounds, and all items were changed by at least one participant.
Participants changed their scores by a mean of 0.70 ± 0.36 points
between rounds.
The intraclass correlation coefﬁcient (95% conﬁdence interval)
increased from 0.85 (0.77–0.91) in round 1 to 0.93 (0.89–0.96) in
round 2, suggesting increased consensus in round 2. Between
rounds, SDs reduced for all individual items except for hospital
admission items and prescribed medication (Table 4), again
suggesting movement toward increased consensus in round 2.
As anticipated, 100% concordance on the priority group (high/
low) was not achieved for any item in either round. No
Table 2 – Items retained at the end of round 1.
Item description %
rating
7–9
%
rating
1–3
Median
(IQR)
Inclusion
reason
Hospital care
(1) Number of hospital admissions (inpatient stay or day case) 95.56 0.00 9 (9–9) Consensus
(2) Number of hospital outpatient appointments 91.11 2.22 9 (8–9) Consensus
(3) Length of stay (e.g., dates or number of nights) 84.44 0.00 9 (8–9) Consensus
(4) Number of operations/procedures undergone 64.44 4.44 8 (6–9) Consensus
(5) Type of operation/procedure undergone 64.44 4.44 8 (6–9) Consensus
(6) Type of professional seen (e.g., consultant/nurse) 53.33 13.33 7 (5–8) Consensus
(7) Number of imaging scans undergone (e.g., x-ray/MRI) 42.22 13.33 6 (5–8) Top 10*
(8) Type of ward stayed in 37.78 11.11 6 (5–8) Top 10*
Emergency care
(9) Number of visits to A&E 91.11 0.00 9 (7–9) Consensus
(10) Number of admissions to hospital, after A&E 80.00 2.22 9 (7–9) Consensus
(11) Number of times paramedic care received 53.33 4.44 7 (5–9) Consensus
Care at a GP surgery or health clinic
(12) Number of appointments at a GP surgery or health clinic 95.56 2.22 9 (9–9) Consensus
(13) Type of professional seen (e.g., GP/nurse/counselor) 80.00 0.00 9 (7–9) Consensus
(14) Number of minor surgery/procedures/treatments undergone 46.67 6.67 6 (5–9) Subgroup†
Care at home
(15) Number of health care or social care professional visits at home (e.g., health
visitor/GP)
86.67 2.22 9 (8–9) Consensus
(16) Type of professional seen at home 80.00 0.00 9 (7–9) Consensus
(17) Number of professional visits for help with daily activities (e.g., washing/
dressing)
55.56 6.67 7 (5–9) Consensus
(18) Equipment (e.g., wheelchairs/portable oxygen/specialist clothing) or home
adaptation (e.g., grab rails/ramp) supplied
44.44 13.33 6 (5–8) Close‡
Remote access care
(19) Number of real-time telephone/computer contacts with health or social care
professional (e.g., with GP or telephone helpline)
68.89 4.44 7 (6–9) Consensus
(20) Type of professional contacted (e.g., doctor/nurse/social worker) 53.33 6.67 7 (5–9) Consensus
Other community care
(21) Number of visits to health care professional in the community (e.g., dentist,
pharmacist, nurse, counselor, and therapist)
80.00 2.22 9 (7–9) Consensus
(22) Number of visits to social care professional in the community (e.g., social
worker/housing worker/drug and alcohol worker)
75.56 2.22 9 (7–9) Consensus
(23) Type of health care professional seen 71.11 4.44 8 (5–9) Consensus
(24) Type of social care professional seen in the community 62.22 4.44 8 (5–9) Consensus
Residential care
(25) Stay in hospice 77.78 6.67 9 (7–9) Consensus
(26) Length of time spent in the hospice 75.56 8.89 8 (7–9) Consensus
(27) Use of short-term respite or rehabilitation care 66.67 6.67 7 (5–9) Consensus
(28) Length of stay in short-term respite or rehabilitation care 62.22 8.89 7 (5–9) Consensus
(29) Living in a nursing home 53.33 11.11 7 (5–9) Consensus
(30) Living in a residential home 48.89 11.11 6 (5–9) Subgroup†
(31) Living in supported accommodation/sheltered housing 46.67 11.11 6 (5–9) Subgroup†
Medication
(32) Number of prescribed medications 68.89 6.67 8 (5–9) Consensus
(33) Name of medication 64.44 4.44 8 (5–9) Consensus
(34) Period taken for (e.g., dates or number of days) 46.67 11.11 6 (5–9) Subgroup†
A&E, accident and emergency; GP, general practitioner; IQR, interquartile range; MRI, magnetic resonance imaging.
⁎ Item included because 415% of participants listed it in their “top 10” choices.
† Item included because 41 subgroup rated it highly.
‡ Item included because it came close to meeting several criteria.
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length of experience.
Twenty-eight respondents commented in round 1, with two
not completing the survey. The content analysis showed that the
hospital and home care categories attracted the highest number
of comments (15 and 11, respectively). Some comments indicated
that the task was cognitively challenging. The most commontheme was that the inclusion of a particular item depended on
another factor including perspective, intervention, setting, con-
dition, patient group, level of detail, recall period, time horizon,
and comparator. Potential issues with patient recall and practical
aspects of administering a resource use questionnaire were also
raised. Seventeen respondents commented in round 2; com-
ments largely focused on useful suggestions for developing an
Table 3 – Items dropped at the end of round 1.
Item description % rating 7–9 % rating 1–3 Median
(IQR)
Hospital care
Number of other procedures undergone 35.56 20.00 6 (4–7)
Number of laboratory tests undergone 35.56 24.44 5 (4–7)
Type of imaging scans undergone 31.11 15.56 6 (5–8)
Type of other procedures undergone 26.67 17.78 5 (4–7)
Type of laboratory tests undergone 22.22 26.67 5 (3–6)
Length of outpatient appointment 15.56 55.56 3 (2–5)
Number of hospital transport journeys (nonemergency) 13.33 42.22 5 (2–5)
Emergency care
Number of ambulance journeys 28.89 17.78 5 (4–7)
Time spent in A&E 15.56 46.67 4 (3–5)
Care at a GP surgery or health clinic
Number of laboratory tests undergone 40.00 22.22 5 (4–7)
Type of minor surgery/procedures/treatments undergone 33.33 11.11 5 (5–7)
Timing of appointments (ofﬁce hours or out of hours) 33.33 31.11 5 (3–9)
Type of laboratory tests undergone 26.67 28.89 5 (3–7)
Care at home
Type of equipment or adaptation supplied 35.56 22.22 5 (4–7)
Time spent with professional at home 33.33 22.22 5 (4–7)
Time spent by professional for help with daily activities 31.11 15.56 5 (5–7)
Remote access care
Duration of contact with professional 24.44 33.33 5 (3–6)
Number of email or SMS (text) communications with health care professional 13.33 42.22 4 (3–5)
Other community care
Use of patient support services in the community (e.g., self-help groups/lunch clubs/
day center)
28.89 15.56 5 (4–7)
Type of support service used 24.44 22.22 5 (4–6)
Residential care
Date moved to nursing home 46.67 13.33 6 (5–9)
Date moved to residential home 42.22 13.33 6 (5–9)
Date moved to supported accommodation/sheltered housing 40.00 13.33 5 (5–9)
Medication
Frequency taken 42.22 15.56 6 (5–9)
Dose taken 42.22 15.56 5 (5–9)
Route taken (e.g., oral/suppository/intravenous) 24.44 35.56 5 (3–6)
A&E, accident and emergency; GP, general practitioner; IQR, interquartile range.
V A L U E I N H E A L T H 2 1 ( 2 0 1 8 ) 6 4 0 – 6 4 9 645instrument, with seven individuals suggesting a modular
approach.Phase 3
In addition to the project team, three Delphi participants were
invited to attend the ﬁnal item selection meeting; because of
other commitments, only one was available. The selection group
identiﬁed community health care questions that could be com-
bined with GP questions for consistency. Items asking about
details of hospital operations or procedures were considered less
important by the more stringent set of consensus rules and were
rejected for the core set of items for the short form (Table 5).
These items could be included in an extended hospital care
module for trials in which admissions (or re-admissions) for
procedures are prevalent. Similarly, most residential care items
(with the exception of hospice stays) did not meet the stringent
consensus rules. Although residential care was thought to be
extremely important in some trials, it was judged by the selection
meeting group to be not relevant in most trials and was therefore
identiﬁed as a suitable candidate for a bolt-on module. Items on
social care did not meet the more stringent consensus rules,
potentially because they were considered to be more relevant to
particular groups, such as older adults; these items couldtherefore be included in a bolt-on social care module. Perhaps
surprisingly, items on medication use were not identiﬁed as
important by the more stringent criterion rules. The selection
committee group felt that medication use was relevant to
participants in most of the trials and should therefore remain
on the included list; nevertheless, future work will look at the
practical aspects of collecting medication data, and medication
may form a separate module in the future.Discussion
On the basis of consensus among health economists, we have
identiﬁed a minimum core set of 10 resource use items that
should be considered for inclusion in a standardized question-
naire for patients (Table 6). We have identiﬁed additional items
that are suitable for inclusion as bolt-on or extended modules
covering further details about hospital procedures, residential
care, and social care. Agreement among participants was excel-
lent [24] and moved toward consensus in the second round.
Results were reasonably stable, suggesting that a third round
would not have signiﬁcantly altered the outcome. Although the
survey was conducted from the viewpoint of the NHS and PSS,
the key inclusions are all items commonly provided by the NHS.
Table 4 – Indicators of response to feedback from round 1.
Item description Mean ± SD Round 2 − Round 1 % rating an item
7–9
% changing
score by
Round 1 Round 2 Change in
mean
Change
in SD
Round 1 Round 2 1 or 2 ≥3
GP appointments 8.5 ± 1.1 8.7 ± 0.9 0.13 −0.23 95.56 97.62 21.43 0.00
GP surgery/procedure 6.3 ± 2.1 5.8 ± 1.9 −0.52 −0.25 46.67 35.71 52.38 2.38
GP professional seen 7.9 ± 1.5 8.2 ± 1.2 0.30 −0.35 80.00 92.86 23.81 2.38
Equipment 6.1 ± 2.2 6.0 ± 1.7 −0.13 −0.48 44.44 33.33 45.24 4.76
Home visits 8.3 ± 1.3 8.5 ± 0.8 0.19 −0.49 86.67 97.62 11.90 2.38
Help with activities 6.9 ± 2.1 6.8 ± 1.5 −0.13 −0.58 55.56 59.52 59.52 4.76
Professional seen at home 7.8 ± 1.6 8.0 ± 1.4 0.20 −0.23 80.00 88.10 21.43 7.14
Admissions after A&E 7.8 ± 1.7 7.9 ± 1.8 0.06 0.06 80.00 88.10 21.43 16.67
Paramedic care 6.8 ± 2.0 6.7 ± 1.3 −0.07 −0.68 53.33 50.00 52.38 7.14
A&E 8.2 ± 1.2 8.5 ± 0.8 0.25 −0.40 91.11 95.24 26.19 2.38
Length of stay 8.2 ± 1.5 8.4 ± 1.4 0.20 −0.02 84.44 92.86 23.81 2.38
Hospital admissions 8.7 ± 0.8 8.6 ± 1.2 −0.14 0.38 95.56 97.62 9.52 2.38
Hospital outpatients 8.2 ± 1.5 8.5 ± 0.9 0.21 −0.52 91.11 97.62 26.19 2.38
Imaging scans 6.2 ± 2.3 5.6 ± 1.8 −0.58 −0.51 42.22 23.81 33.33 9.52
Operation/procedure 7.2 ± 2.1 7.5 ± 1.4 0.28 −0.75 64.44 78.57 45.24 7.14
Specialty/ward 6.2 ± 2.0 6.1 ± 1.7 −0.08 −0.26 37.78 38.10 45.24 7.14
Operation type 7.1 ± 2.0 7.3 ± 1.4 0.17 −0.59 64.44 71.43 35.71 7.14
Professional seen
outpatient
6.2 ± 2.2 6.4 ± 1.7 0.16 −0.49 53.33 57.14 47.62 7.14
Name of medication 7.1 ± 2.1 7.3 ± 1.9 0.17 −0.20 64.44 73.81 42.86 14.29
Prescribed medication 7.2 ± 2.3 6.7 ± 2.3 −0.51 0.03 68.89 64.29 35.71 9.52
Period taken for 6.4 ± 2.3 6.3 ± 1.8 −0.09 −0.41 46.67 40.48 42.86 9.52
Community health care 7.8 ± 1.7 8.1 ± 1.3 0.29 −0.41 80.00 88.10 33.33 4.76
Community social care 7.7 ± 1.8 8.0 ± 1.2 0.22 −0.55 75.56 85.71 35.71 4.76
Health professional seen 7.2 ± 2.0 7.5 ± 1.5 0.30 −0.56 71.11 78.57 33.33 7.14
Social care professional
seen
7.0 ± 2.2 7.4 ± 1.6 0.38 −0.56 62.22 73.81 35.71 9.52
Telephone/computer
contacts
7.2 ± 1.9 7.0 ± 1.5 −0.27 −0.43 68.89 64.29 50.00 2.38
Professional contacted 6.6 ± 2.0 6.8 ± 1.5 0.16 −0.51 53.33 54.76 52.38 2.38
Respite length of stay 6.9 ± 2.3 6.7 ± 1.9 −0.24 −0.36 62.22 64.29 57.14 2.38
Hospice length of stay 7.4 ± 2.1 7.4 ± 2.1 −0.02 −0.02 75.56 78.57 33.33 7.14
Nursing home 6.8 ± 2.4 6.6 ± 2.0 −0.14 −0.42 53.33 57.14 57.14 4.76
Residential home 6.7 ± 2.4 6.2 ± 2.1 −0.50 −0.28 48.89 40.48 42.86 11.90
Supported accommodation 6.4 ± 2.5 5.9 ± 2.0 −0.52 −0.52 46.67 30.95 40.48 9.52
Stay in hospice 7.5 ± 2.1 7.6 ± 2.1 0.13 −0.05 77.78 80.95 19.05 11.90
Respite care 7.0 ± 2.2 6.9 ± 1.9 −0.16 −0.32 66.67 73.81 47.62 7.14
A&E, accident and emergency; GP, general practitioner.
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module for trial populations in which it is thought to be
prevalent.
Knapp and Beecham [25] identiﬁed “reduced lists” of key
services that could be measured to capture over 90% of the total
costs of health and social care in patient groups with mental
health conditions. The study indicated that, in principle, captur-
ing a fairly small number of key items of resource use can lead to
adequate cost information, with diminishing returns gained by
further data collection. Nevertheless, although there was some
overlap with the items we identiﬁed in this study (hospital
inpatient and outpatient, residential care, and GP care), the
nature of the patient group meant that social services played a
considerably more prominent role.
Generic resource use measures developed to date include the
Annotated Patient Cost Questionnaire [26] and the Client Service
Receipt Inventory [27]. The former was designed as a generic
patient-reported instrument. Although empirical evidence sug-
gests that the questionnaire performs well [28], it has not beenwidely adopted (possibly because of the length of the question-
naire necessitating substantial work to generate an instrument
for a trial). The latter has been tested extensively, demonstrating
good consistency, reliability, and validity [29–32] and is well used.
Nevertheless, it was developed in the context of psychiatric care,
was designed for interview administration rather than patient
self-completion, and has been subject to uncontrolled modiﬁca-
tion over the years. Standardization of data collection has also
been attempted in the context of cancer care [33], and a generic
Dutch language instrument has been developed [34]. Neverthe-
less, neither implementation combines full standardization
across all disease areas with a concise instrument and neither
attempts to determine relevant content through a documented
consensus process involving health economists.
Strengths of the study include the recruitment of the panel of
expert participants, who were representative of a wide range of
experience and had extensive NHS research experience. The
stability of the panel was good with less than 10% attrition, and
the study beneﬁted from patient involvement in the study team.
Table 5 – Final outcomes for items after round 2.
Item description %
rating
7–9
% rating
8 or 9
%
rating
1–3
Outcome: pre-
agreed rules
Outcome: more
stringent rules
Final outcome after item
selection meeting
Hospital
outpatients
97.62 80.95 0.00 Include Include Short form
Hospital
admissions
97.62 90.48 2.38 Include Include Short form
Length of stay 92.86 85.71 2.38 Include Include Short form
Operation/
procedure
78.57 61.90 0.00 Include Exclude Extended hospital care
module
Operation type 71.43 54.76 0.00 Include Exclude Extended hospital care
module
A&E 95.24 88.10 0.00 Include Include Short form
Admissions after
A&E
88.10 76.19 7.14 Include Include Short form
GP appointments 97.62 95.24 0.00 Include Include Short form
GP professional
seen
92.86 78.57 0.00 Include Include Short form
Home visits 97.62 85.71 0.00 Include Include Short form
Professional seen
at home
88.10 69.05 2.38 Include Exclude Short form
Community
health care
88.10 78.57 2.38 Include Include Combined with GP
appointments in short
form
Community social
care
85.71 69.05 0.00 Include Exclude Social care module
Health
professional
seen
78.57 57.14 2.38 Include Exclude Combined with GP
appointments in short
form
Social care
professional
seen
73.81 52.38 2.38 Include Exclude Social care module
Stay in hospice 80.95 73.81 9.52 Include Include Residential care module
Hospice length of
stay
78.57 66.67 11.90 Include Exclude Residential care module
Respite care 73.81 40.48 7.14 Include Exclude Residential care module
Name of
medication
73.81 59.52 4.76 Include Exclude Short form
Professional seen
outpatient
57.14 26.19 4.76 Exclude Exclude
Specialty/ward 38.10 16.67 9.52 Exclude Exclude
Imaging scans 23.81 11.90 9.52 Exclude Exclude
Paramedic care 50.00 23.81 0.00 Exclude Exclude
GP surgery/
procedure
35.71 16.67 9.52 Exclude Exclude
Help with
activities
59.52 30.95 2.38 Exclude Exclude
Equipment 33.33 21.43 2.38 Exclude Exclude
Telephone/
computer
contacts
64.29 38.10 2.38 Exclude Exclude
Professional
contacted
54.76 35.71 2.38 Exclude Exclude
Respite length of
stay
64.29 40.48 7.14 Exclude Exclude
Nursing home 57.14 35.71 9.52 Exclude Exclude
Residential home 40.48 28.57 11.90 Exclude Exclude
Supported
accommodation
30.95 19.05 11.90 Exclude Exclude
Prescribed
medication
64.29 47.62 14.29 Exclude Exclude
Period taken for 40.48 28.57 4.76 Exclude Exclude
A&E, accident and emergency; GP, general practitioner.
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Table 6 – Items included in the ﬁnal core set.
Type of care Item
1. Hospital care Number of hospital admissions (inpatient stay or day case)
2. Hospital care Length of stay (e.g., dates or number of nights)
3. Hospital care Number of hospital outpatient appointments
4. Emergency care Number of visits to A&E
5. Emergency care Number of admissions to hospital, after A&E
6. Care at a GP surgery or health clinic or other community setting Number of appointments
7. Care at a GP surgery or health clinic or other community setting Type of professional seen
8. Health care at home Number of health care professional visits at home
9. Health care at home Type of health care professional seen at home
10. Medication Name/class of medication
A&E, accident and emergency; GP, general practitioner.
V A L U E I N H E A L T H 2 1 ( 2 0 1 8 ) 6 4 0 – 6 4 9648Established methods for conducting Delphi surveys were fol-
lowed, with consensus criteria deﬁned in advance of conducting
each round. There was clear consensus for items ultimately
included in the core set. Nevertheless, there may also be some
limitations. Almost all the respondents came from an academic
background; wider participation from industry representatives
may have been beneﬁcial in terms of generalizability, although
their experience of NHS research would have been more limited.
A larger sample participating in the Delphi survey would have
been preferable; there is, however, no statistical basis on which to
determine necessary sample size for a Delphi survey, and
previous studies including fewer participants have been shown
to produce reliable results [35]. Respondents were asked to rate
the type of resource use (e.g., hospital or GP care) as well as the
measurement information (such as the number of nights or
appointments) simultaneously. The task was therefore cogni-
tively challenging, with a large set of factors to bear in mind
while responding; it is possible that participants may not have
taken everything relevant into account.
The items identiﬁed are those considered most important by
professional health economists for inclusion in a core set of
resource use items. Work is now needed to identify the most
appropriate way to measure these items to ensure patient
acceptability and comprehensibility. There was evidence from
the comments that some participants were considering patient
ability to respond to questions. For example, one respondent
commented that “… many patient groups are very confused
about which services and professionals have visited them at
home.” This requires further investigation with patient groups.
Patients were not recruited to the Delphi panel, because the task
was not meaningful in the context of the UK health care system
in which patients do not pay for services at the point of use. The
patient perspective was, however, represented during the study
by the PPI member of the project team. Translation of the
questionnaire to other languages (and other health care systems)
also requires further investigation; given the common nature of
the items included, it is possible that it will extend readily to
other health care systems.
In this project, we have focused on an NHS and PSS perspec-
tive. There will commonly be requirements for additional data to
be collected; any future instrument should take this into account
through modularization, allowing modiﬁcations in a controlled
fashion only, with alterations recorded. It is also likely that the
resource use associated with the intervention itself will need to
be collected separately. The developed instrument should be
reviewed regularly to ensure that it remains current; for example,
remote access care does not feature in our short form, but may
become more pertinent in future if online consultations becomecommon. We plan to develop a core module based on the 10
items identiﬁed in this study, working with PPI representatives to
convert the items into questions that are meaningful and
straightforward to answer.Conclusions
The consensus on which items are important to health econo-
mists working on clinical trials in a generic context suggests that
a standardized instrument for core items is feasible. The list of
items identiﬁed forms a coherent set that is potentially relevant
to most trials, conditions, and patient groups; it is therefore
suitable for further development into a ﬂexible instrument with
additional extended and bolt-on modules. Collecting cost data in
a manner that is simultaneously concise, understandable for
patients, valid, precise, consistent between trials, and general-
izable is challenging. We have provided much needed evidence
that it may be possible to develop a standardized instrument that
goes some way to meeting those challenges, on the basis of the
most important cost items.Acknowledgments
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